Business Context and Reporting Period
This Form 8-K was filed by Blackbaud, Inc. on January 27, 2012. The report addresses a procedural update regarding the company's proposed acquisition of Convio, Inc., a Delaware corporation.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes and Events
- Regulatory Filing Update: Blackbaud voluntarily withdrew its Premerger Notification and Report Form (filed January 19, 2012) with the Federal Trade Commission (FTC) and Department of Justice (DOJ).
- Refiling Schedule: The company notified regulators it would refile the form on February 6, 2012, to facilitate the review process.
- Waiting Period: Upon refiling, the Hart-Scott-Rodino Act waiting period is scheduled to expire at 11:59 p.m. on February 21, 2012, unless terminated early or extended by a request for additional information.
- Tender Offer Status: Blackbaud, via its subsidiary Caribou Acquisition Corporation, launched a tender offer for all outstanding Convio common stock on January 25, 2012.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the acquisition and the potential combined business. Management explicitly states there is no guarantee the acquisition will be completed, close within the anticipated timeframe, or realize expected benefits. Risks include regulatory delays, diversion of resources, and uncertainties affecting both companies as detailed in their respective Form 10-K filings.
Investor Verification Checklist
- Verify the status of the tender offer statement (Schedule TO) and Convio's solicitation/recommendation statement (Schedule 14D-9) on the SEC website.
- Monitor for any "Second Request" for additional information from the FTC or DOJ prior to the February 21, 2012 expiration date.
- Review the risk factors in Blackbaud's and Convio's most recent Annual Reports on Form 10-K.
- Confirm the final closing date of the acquisition, as it is subject to regulatory approval and other conditions.